Polymersomes incorporating highly emissive probes
First Claim
Patent Images
1. A polymersome comprising:
- (i) a plurality of amphiphilic copolymers; and
(ii) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane.
2 Assignments
0 Petitions
Accused Products
Abstract
The instant invention concerns compositions comprising polymersomes, visible or near infrared emissive agents, and optionally a targeting moiety associated with a surface of the polymersome. The invention also relates to use of these compositions in the treatment of disease and in imaging methodology.
-
Citations
184 Claims
-
1. A polymersome comprising:
-
(i) a plurality of amphiphilic copolymers; and
(ii) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)
-
-
21. The polymersome of 17, wherein the said multi(porphyrin) imaging agent comprises a meso-to-meso ethyne- or butadiyne-bridged linkage topology, said imaging agent being capable of emitting in the 600-to-100 nm spectral regime.
-
52. A polymersome comprising:
-
(i) a plurality of amphiphilic copolymers;
(ii) at least one visible- or near infrared-emissive agent that is segregated within the polymersome membrane; and
(iii) at least one targeting moiety associated with a surface of the polymersome. - View Dependent Claims (53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106)
-
-
75. The polymersome of 55, wherein the said multi(porphyrin) imaging agent comprises a meso-to-meso ethyne- or butadiyne-bridged linkage topology, said imaging agent being capable of emitting in the 600-to-1100 nm spectral regime.
-
107. A method of delivering an agent to a biological situs in a tissue or organism comprising administering to the tissue or organism a polymersome having the agent and comprising (a) a plurality of amphiphilic copolymers;
- (b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
(c) at least one targeting moiety associated with a surface of the polymersome. - View Dependent Claims (108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130)
- (b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
-
131. A method of ascertaining the presence or absence of a disease state in an organism or tissue comprising:
-
administering a polymersome to a patient, the polymersome comprising (a) a plurality of amphiphilic copolymers;
(b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
(c) at least one targeting moiety associated with a surface of the polymersome;
providing an instrument optically coupled to a light source, a light detector, or both, and operating the instrument to monitor the amount or distribution of the phorphinato imaging agent within the organism or tissue. - View Dependent Claims (132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152)
-
-
153. An in vivo method of diagnostics or imaging comprising:
-
contacting a polymersome with tissue within an organism, the polymersome comprising (a) a plurality of amphiphilic copolymers;
(b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
(c) at least one targeting moiety associated with a surface of the polymersome;
providing an instrument optically coupled to a light source, a light detector, or both, and using the instrument to monitor the amount of the polymersome at a situs within the tissue. - View Dependent Claims (154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165)
-
-
166. An in vitro diagnostic method comprising:
-
contacting a polymersome with isolated cells, mixtures of cells, or specific cell lines, with the polymersome comprising (a) a plurality of amphiphilic copolymers;
(b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
(c) at least one targeting moiety associated with a surface of the polymersome;
providing an instrument optically coupled to a light source, a light detector, or both, and using the instrument to monitor cell-surface-to-polymersome binding. - View Dependent Claims (167, 168, 169)
-
-
170. A method for histological labeling, molecular classification of cell surface markers, or guiding the development of novel directed therapeutic strategies, comprising
contacting a polymersome with isolated cells, mixtures of cells, or specific cell lines, with the polymersome comprising (a) a plurality of amphiphilic copolymers; - (b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
(c) at least one targeting moiety associated with a surface of the polymersome;
providing an instrument optically coupled to a light source, a light detector, or both, and using the instrument to monitor cell-surface-to-polymersome binding. - View Dependent Claims (171)
- (b) at least one visible- or near infrared-emissive agent that is dispersed within the polymersome membrane; and
- 172. A method of modulating the emission properties of a visible- or near infrared-emissive agent comprising at least two covalently bound moieties, said emissive agent being within a polymeric material, wherein at least one of the bound moieties comprises an ancillary substituent, the size and chemical constitution of said substituent being selected to provide said modulation.
Specification